drugset / Trial / NCT04633928

Nasal Septum Perforation Treatment Using Tissue Engineered Cartilage Graft

NCT04633928 ↗

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the safety and feasibility of implanting an engineered cartilage tissue in an interposition graft with a temporoparietal fascia (TPF) flap to repair medium size septal perforation. The engineered cartilage graft is obtained by culturing expanded autologous nasal chondrocytes within a collagen type I/III membrane. In addition, first data on efficacy will be collected.

Timeline

Start
2021-04-09
Primary completion
2023-04-24
Completion
2023-04-24

Drugs

EvaluationDrugModalityDoseRoute
Subject N-TEC Unknown — Other

Indications

No indication recorded.